HomeBiotechnology

Biotechnology

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadline in Securities Class Action – BMRN

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadline in Securities Class Action – BMRN

October 25, 2020

SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 24, 2020

RETA CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.

RETA CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.

October 24, 2020

ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm – RETA

ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm – RETA

October 23, 2020

Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited

Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited

October 23, 2020

MERGER ALERT – CIT, BBIO, and LSAC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

MERGER ALERT – CIT, BBIO, and LSAC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

October 23, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates BMRN, CACC Investors on Securities Class Actions, Encourages Investors with Losses to Contact Firm

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates BMRN, CACC Investors on Securities Class Actions, Encourages Investors with Losses to Contact Firm

October 23, 2020

Ascendis Pharma A/S Receives Orphan Designation for TransCon(TM) PTH for Treatment of Hypoparathyroidism in Europe

Ascendis Pharma A/S Receives Orphan Designation for TransCon(TM) PTH for Treatment of Hypoparathyroidism in Europe

October 23, 2020

Will Coronavirus Woes Affect Gilead’s (GILD) Q3 Earnings?

Will Coronavirus Woes Affect Gilead’s (GILD) Q3 Earnings?

October 23, 2020

U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderately Elevated Triglyceride (TG) Levels Despite Well-Controlled Low-Density Lipoprotein (LDL)-Cholesterol

U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderately Elevated Triglyceride (TG) Levels Despite Well-Controlled Low-Density Lipoprotein (LDL)-Cholesterol

October 23, 2020

« 1 … 466 467 468 469 470 … 543 »